Neurology Today Videos On Demand
ALS/Frontotemporal Dementia: New research identifies a gene-specific biomarker: A new study presented at this year's AAN Annual Meeting suggests that transthyretin could serve as the first gene-specific biomarker for ALS and frontotemporal dementia. Neurology Today Editor-in-chief Steven P. Ringel, MD, FAAN, and Associate Editor Robert Holloway Jr., MD, FAAN, discuss the implications of the findings with Brent Fogel, MD, PhD, an assistant professor in the neurogenetics program at the David Geffen School of Medicine at the University of California, Los Angeles and a member of the Neurology Today editorial advisory board. Watch the video: http://bit.ly/youtube_ALS-FTD. Read the Neurology Today story: http://bit.ly/1B65cZd.
Stroke: A low-cost mobile telemedicine system for pre-hospital assessment: A new proof-of-principle study presented at the AAN Annual Meeting found that inexpensive tablets and video conferencing software could reliably screen stroke patients en route to the hospital using the National Institutes of Health Stroke Scale. James C. Grotta, MD, FAAN, a professor of neurology at the University of Texas Medical School, discusses the study and other promising advances in assessing and treating stroke with Neurology Today Editor-in-chief Steven P. Ringel, MD, FAAN, and Associate Editor Robert Holloway Jr., MD, FAAN. Watch the video here: http://bit.ly/NT-video-telestroke. Read the Neurology Today story: http://bit.ly/1GhGeEQ.